PGT-A Counselling in Guwahati: Which IVF Embryo Tests Are Worth Discussing?

Patients in Guwahati considering preimplantation genetic testing should distinguish PGT-A, PGT-M and PGT-SR before accepting a laboratory add-on. These tests answer different questions, and screening does not guarantee a healthy pregnancy or a transferable embryo.

PGT-A assesses chromosome copy-number patterns in sampled embryo cells; PGT-M targets a known familial single-gene condition; PGT-SR addresses certain structural chromosome rearrangements. A carrier result does not automatically indicate PGT-A. A genetics professional should explain the indication, inheritance pattern, embryo-biopsy limitations and alternatives, including prenatal testing where relevant. The meaning of mosaic or inconclusive results requires careful counselling.

Biopsy samples a limited number of cells and results may not perfectly represent every cell of the embryo. Embryo development, the number available for testing and the risk of no suitable embryo after testing affect the value proposition. PGT-A is not a universal guarantee of higher live-birth chances for all patient groups. Ask whether the clinician recommends it for a specific reason and what evidence supports that recommendation.

A written quote should separate IVF stimulation, retrieval, ICSI if used, culture to the biopsy stage, biopsy, genetic laboratory analysis, vitrification, storage, warming and transfer. Some advertised charges refer to one embryo while others bundle a group, so ask how additional embryos are billed. Patients should know what happens financially if embryos do not reach biopsy stage or results are inconclusive.

A city keyword does not establish that HomeIVF runs a genetics lab or retrieval centre in Guwahati. The actual embryology and testing facilities must be identified. Home-based blood collection or teleconsultation may be possible only where verified; biopsy, embryology, genetics sample handling and embryo transfer are facility-based. A remote second opinion may help clarify the proposed test before paying for it.

Home-supported care should make the treatment pathway easier to navigate, not lower the safety threshold. Through HomeIVF's doctor-led model, some consultations or prescribed tests may potentially happen remotely or at home where clinically suitable and locally available. Required scans, intrauterine insemination, egg retrieval, sperm or embryo laboratory work, cryopreservation and embryo transfer cannot be described as home procedures. Ask exactly which steps the responsible centre will provide, which outside facilities are involved and how urgent concerns are handled.

A practical treatment plan identifies the clinician, each required scan and laboratory, the procedure centre and the point of contact if a result changes the schedule. No online article can establish that a particular address is served. Before arranging travel or time off, request confirmation of which activities are possible remotely and which must take place in person. Patients should not receive assurances about travel distances, waiting times or next-day appointments unless the centre has verified those operational details.

Financial planning is part of informed consent. Ask for a line-item schedule of diagnostic work, medication, facility procedures, embryology, any proposed additional test and possible future storage or transfer. Some patients will need only a fraction of those items. Determine what is non-refundable when a cycle changes course. Repeated ineffective treatment can be costly even if each quoted attempt appears less expensive; equally, an expensive add-on is not automatically evidence-based.

Before agreeing to a change, ask whether it addresses a documented problem in the current case or merely reacts to a disappointing outcome. The team should describe the expected clinical purpose, credible alternative choices and possible disadvantages. Written explanations are particularly valuable when IUI, conventional IVF, ICSI, egg freezing or genetic testing are being compared. Neither a clinic location nor a branded care model replaces the need for informed consent and accountable clinician review.

Does PGT-A make IVF successful?

No. It provides limited genetic screening information and does not guarantee embryo viability or pregnancy.

Is PGT-M the same as PGT-A?

No. PGT-M addresses a specific known monogenic risk; PGT-A assesses chromosome copy-number patterns.

Can embryo testing be done at home?

No. Embryo biopsy and genetic testing need specialised laboratory and consent procedures.

A useful follow-up question is whether the proposed next step can reasonably be postponed without changing the clinical objective. Ask the responsible clinician to name the evidence they are relying on, any patient-specific contraindications, and the consequences if a test or procedure is cancelled. Confirm the person responsible for discussing unexpected findings, and retain copies of the written plan. Neither a search result nor a medical infographic replaces individualized assessment. Medical care should be tailored to the exact diagnosis, rather than driven by package labels or unsupported promises.

Patients often receive several reports from different laboratories. Save the units, reference ranges and collection dates, because apparently conflicting values can reflect different methods. Ask the team to explain what can be compared and what cannot. A clinical plan is strongest when the person giving medication instructions can see the relevant imaging and laboratory results. If an urgent symptom develops, seek appropriate direct assessment instead of waiting for a routine online reply.

• HFEA — Fertility treatment add-ons and evidence ratings
• ASRM — PGT-M indications and management (2023)